JP2011006480A5 - - Google Patents

Download PDF

Info

Publication number
JP2011006480A5
JP2011006480A5 JP2010228356A JP2010228356A JP2011006480A5 JP 2011006480 A5 JP2011006480 A5 JP 2011006480A5 JP 2010228356 A JP2010228356 A JP 2010228356A JP 2010228356 A JP2010228356 A JP 2010228356A JP 2011006480 A5 JP2011006480 A5 JP 2011006480A5
Authority
JP
Japan
Prior art keywords
group
compound
cancer
lower alkyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010228356A
Other languages
English (en)
Japanese (ja)
Other versions
JP5679757B2 (ja
JP2011006480A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011006480A publication Critical patent/JP2011006480A/ja
Publication of JP2011006480A5 publication Critical patent/JP2011006480A5/ja
Application granted granted Critical
Publication of JP5679757B2 publication Critical patent/JP5679757B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2010228356A 2002-11-07 2010-10-08 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法 Expired - Fee Related JP5679757B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42535202P 2002-11-07 2002-11-07
US60/425,352 2002-11-07
US47374303P 2003-05-27 2003-05-27
US60/473,743 2003-05-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005507102A Division JP4641941B2 (ja) 2002-11-07 2003-11-07 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013147528A Division JP2013213054A (ja) 2002-11-07 2013-07-16 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法

Publications (3)

Publication Number Publication Date
JP2011006480A JP2011006480A (ja) 2011-01-13
JP2011006480A5 true JP2011006480A5 (US20070167479A1-20070719-C00034.png) 2011-11-17
JP5679757B2 JP5679757B2 (ja) 2015-03-04

Family

ID=32314587

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2005507102A Expired - Fee Related JP4641941B2 (ja) 2002-11-07 2003-11-07 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法
JP2010228356A Expired - Fee Related JP5679757B2 (ja) 2002-11-07 2010-10-08 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法
JP2013147528A Pending JP2013213054A (ja) 2002-11-07 2013-07-16 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2005507102A Expired - Fee Related JP4641941B2 (ja) 2002-11-07 2003-11-07 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013147528A Pending JP2013213054A (ja) 2002-11-07 2013-07-16 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法

Country Status (14)

Country Link
US (2) US20040152708A1 (US20070167479A1-20070719-C00034.png)
EP (3) EP2135867B1 (US20070167479A1-20070719-C00034.png)
JP (3) JP4641941B2 (US20070167479A1-20070719-C00034.png)
KR (2) KR100966667B1 (US20070167479A1-20070719-C00034.png)
AT (1) ATE452888T1 (US20070167479A1-20070719-C00034.png)
AU (1) AU2003291337B2 (US20070167479A1-20070719-C00034.png)
CA (1) CA2505368C (US20070167479A1-20070719-C00034.png)
CY (1) CY1110295T1 (US20070167479A1-20070719-C00034.png)
DE (1) DE60330703D1 (US20070167479A1-20070719-C00034.png)
DK (1) DK1562941T3 (US20070167479A1-20070719-C00034.png)
ES (2) ES2436296T3 (US20070167479A1-20070719-C00034.png)
PT (1) PT1562941E (US20070167479A1-20070719-C00034.png)
SI (1) SI1562941T1 (US20070167479A1-20070719-C00034.png)
WO (1) WO2004043954A2 (US20070167479A1-20070719-C00034.png)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2273083C (en) 1996-12-03 2012-09-18 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US8618085B2 (en) * 2000-04-28 2013-12-31 Koasn Biosciences Incorporated Therapeutic formulations of desoxyepothilones
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US7384964B2 (en) * 2002-08-23 2008-06-10 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
ATE350383T1 (de) 2002-08-23 2007-01-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
CN101088998A (zh) * 2002-11-07 2007-12-19 科桑生物科学公司 反式-9,10-脱氢埃坡霉素c和d,其类似物以及制备这些化合物的方法
EP2135867B1 (en) * 2002-11-07 2013-09-25 Kosan Biosciences Incorporated Trans-9, 10-dehydroepothilone C and trans-9, 10-dehydroepothilone D, analogs thereof and methods of making the same
BRPI0408891A (pt) * 2003-03-28 2006-04-11 Kosan Biosciences Inc dispositivos, métodos, e composições para prevenir restenose
CA2539801A1 (en) * 2003-10-09 2005-04-21 Kosan Biosciences, Inc. Therapeutic formulations
US20050215604A1 (en) * 2004-03-26 2005-09-29 Kosan Biosciences, Inc. Combination therapies with epothilones and carboplatin
CA2686827C (en) * 2006-12-14 2014-09-16 Aileron Therapeutics, Inc. Bis-sulfhydryl macrocyclization systems
US7981998B2 (en) * 2006-12-14 2011-07-19 Aileron Therapeutics, Inc. Bis-sulfhydryl macrocyclization systems
EP2118123B1 (en) 2007-01-31 2015-10-14 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
EP3301108A1 (en) 2007-02-23 2018-04-04 Aileron Therapeutics, Inc. Triazole macrocycle systems
WO2008121767A2 (en) 2007-03-28 2008-10-09 President And Fellows Of Harvard College Stitched polypeptides
WO2008141130A1 (en) * 2007-05-11 2008-11-20 Kosan Biosciences, Inc. Process for the preparation of epothilones
US8030503B2 (en) 2007-05-11 2011-10-04 Kosan Biosciences Incorporated Process for the preparation of epothilones
BRPI1006139A2 (pt) 2009-01-14 2017-05-30 Aileron Therapeutics Inc macrociclos peptidomiméticos
EP2480565A4 (en) 2009-09-22 2014-01-01 Aileron Therapeutics Inc PEPTIDOMIMETIC MACROCYCLES
WO2012021876A2 (en) 2010-08-13 2012-02-16 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
AU2012326026B2 (en) 2011-10-18 2017-04-13 Aileron Therapeutics, Inc. Peptidomimetic macrocyles
US8987414B2 (en) 2012-02-15 2015-03-24 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
KR102112373B1 (ko) 2012-02-15 2020-05-18 에일러론 테라퓨틱스 인코포레이티드 펩티드모방체 마크로사이클
CA2776178A1 (en) * 2012-04-05 2013-10-05 Hydro-Quebec Ionic compounds
SG11201503052RA (en) 2012-11-01 2015-05-28 Aileron Therapeutics Inc Disubstituted amino acids and methods of preparation and use thereof
WO2016049359A1 (en) 2014-09-24 2016-03-31 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
CN107106642B (zh) 2014-09-24 2021-02-26 艾瑞朗医疗公司 拟肽大环化合物及其制剂
AU2016235424A1 (en) 2015-03-20 2017-10-05 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
US10059741B2 (en) 2015-07-01 2018-08-28 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
CN108368161A (zh) 2015-09-10 2018-08-03 艾瑞朗医疗公司 作为mcl-1调节剂的拟肽大环化合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE194767T1 (de) 1992-03-23 2000-08-15 Univ Georgetown In liposomen verkapseltes taxol und verwendungsverfahren
AU6833994A (en) 1993-05-17 1994-12-12 Liposome Company, Inc., The Incorporation of taxol into liposomes and gels
US5415869A (en) 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
US5662883A (en) 1995-01-10 1997-09-02 Nanosystems L.L.C. Microprecipitation of micro-nanoparticulate pharmaceutical agents
US5534270A (en) 1995-02-09 1996-07-09 Nanosystems Llc Method of preparing stable drug nanoparticles
US5510118A (en) 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
AU735900B2 (en) 1996-03-12 2001-07-19 Pg-Txl Company, L.P. Water soluble paclitaxel prodrugs
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
NZ506389A (en) 1998-02-05 2003-07-25 Novartis Ag Pharmaceutical compositions containing epothilone which can be optionally lyophilised
US6596875B2 (en) * 2000-02-07 2003-07-22 James David White Method for synthesizing epothilones and epothilone analogs
DE19954229A1 (de) * 1999-11-04 2001-05-10 Schering Ag Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
DE19907480A1 (de) * 1999-02-11 2000-08-17 Schering Ag Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
US6156373A (en) 1999-05-03 2000-12-05 Scimed Life Systems, Inc. Medical device coating methods and devices
MXPA01011981A (es) 1999-05-24 2003-09-04 Sonus Pharma Inc Vehiculo de emulsion para farmacos poco solubles.
GB9918429D0 (en) 1999-08-04 1999-10-06 Novartis Ag Organic compounds
MXPA02010565A (es) 2000-04-28 2004-05-17 Kosan Biosciences Inc Produccion de policetidos.
AU2001266583A1 (en) * 2000-05-26 2001-12-11 Kosan Biosciences, Inc. Epothilone derivatives and methods for making and using the same
US6906188B2 (en) * 2001-04-30 2005-06-14 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Method for synthesizing epothilones and epothilone analogs
WO2003022844A2 (en) * 2001-09-06 2003-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones intermediates thereto and analogues thereof
US7649006B2 (en) * 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
ATE350383T1 (de) * 2002-08-23 2007-01-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
US6921769B2 (en) * 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
EP2135867B1 (en) * 2002-11-07 2013-09-25 Kosan Biosciences Incorporated Trans-9, 10-dehydroepothilone C and trans-9, 10-dehydroepothilone D, analogs thereof and methods of making the same

Similar Documents

Publication Publication Date Title
JP2011006480A5 (US20070167479A1-20070719-C00034.png)
JP2017533968A5 (US20070167479A1-20070719-C00034.png)
JP2013510120A5 (US20070167479A1-20070719-C00034.png)
JP2013513613A5 (US20070167479A1-20070719-C00034.png)
JP2013537203A5 (US20070167479A1-20070719-C00034.png)
JP2013508279A5 (US20070167479A1-20070719-C00034.png)
JP2017531038A5 (US20070167479A1-20070719-C00034.png)
JP2014508752A5 (US20070167479A1-20070719-C00034.png)
JP2017537949A5 (US20070167479A1-20070719-C00034.png)
JP2014508804A5 (US20070167479A1-20070719-C00034.png)
JP2011526924A5 (US20070167479A1-20070719-C00034.png)
JP2011520906A5 (US20070167479A1-20070719-C00034.png)
JP2013532652A5 (US20070167479A1-20070719-C00034.png)
JP2012506872A5 (US20070167479A1-20070719-C00034.png)
JP2010525056A5 (US20070167479A1-20070719-C00034.png)
JP2010523522A5 (US20070167479A1-20070719-C00034.png)
JP2014518266A5 (US20070167479A1-20070719-C00034.png)
JP2007522142A5 (US20070167479A1-20070719-C00034.png)
JP2015500843A5 (US20070167479A1-20070719-C00034.png)
EP2592070A3 (en) Tetrazole-substituted arylamides
JP2010518094A5 (US20070167479A1-20070719-C00034.png)
JP2014505107A5 (US20070167479A1-20070719-C00034.png)
JP2016040288A5 (US20070167479A1-20070719-C00034.png)
JP2011507896A5 (US20070167479A1-20070719-C00034.png)
JP2015508092A5 (US20070167479A1-20070719-C00034.png)